OTC - ACTIVE INGREDIENT SECTION
Active Ingredients Purpose
Hydrocortisone 1% ................. Anti-itch
Post Peel Protectant Anti-Itch Cream
- Manufacturer
- Vi Medical Products Inc. | VEGE-KURL, INC
- Effective date
- 2016-04-21
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-05-31 22:45:46
Label at a glance#
ProductPost peel Protectant Vitality Institute
Active ingredientHYDROCORTISONE
Label structure8 sections
Label contents#
Full prescribing information#
OTC - PURPOSE SECTION
Uses
- For the temporary relief of of itching associated with minor skin irritations and rashes due to
- Eczema
- insect bites
- poison ivy, poison oak, poison sumac
- soaps and detergents cosmetics
- jewelry
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
- Keep out of reach of children. If swallowed, get medial help or contact a Poison Control Center rigth away
INDICATIONS & USAGE SECTION
Stop use and ask a doctor
if condition worsens, or if symptoms persist for more than 7 day or clear up and occur again within a few days, do not use this or any other hydrocortisone products unless you hav consulted a doctor.
WARNINGS SECTION
Warnings
- For external use only
- Avoid Contact with eyes
DOSAGE & ADMINISTRATION SECTION
Directions
- Adults and children under 2 years of age and older: Appyl to affected area not more than 3 to 4 times daily
- Children under 2 years of age: Do not use, consult a doctor
INACTIVE INGREDIENT SECTION
Inactive Ingredients
Water (Aqua), Cyclopentasiloxane, Demthicone/Vinyl Dimethicone Crosspolymer, Aloe Barbadensis Leaf Juice, Glycerin, Cetearyl Alcohol, Ceteareth-20, Caprylic/Capric Triglyceride, Cetyl Alcohol, Ammonium Acryloyldimethyltaurate/VP Copolymer, Avena Sativa (Oat) Kernel Extract, Chrysanthemum Pathenium (Feverfew) Extract, Tocophoneryl Acetate, Allantoint, Ethylhexylglycerin, Phenoxyethanol
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Vitality Institute
Skin Care System
Post Peel Protectant
Anti-itch Cream
30 mL/1 FL OZ
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| HYDROCORTISONE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70484-001-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-fb83-f424-e053-dadaa90a57ce | Post Peel Protectant Anti-Itch Cream |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70484-001-01 | Post peel ProtectantVitality Institute | 30 mL in 1 JAR | CREAM | 30 | 4 | |
| 70484-001-02 | Post peel ProtectantVitality Institute | 1 in 1 BOX | CREAM | 1 | 4 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Post peel Protectant Vitality Institute
- Hydrocortisone
- WATER
- CYCLOMETHICONE 5
- DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE)
- ALOE VERA LEAF
- GLYCERIN
- CETOSTEARYL ALCOHOL
- POLYOXYL 20 CETOSTEARYL ETHER
- MEDIUM-CHAIN TRIGLYCERIDES
- CETYL ALCOHOL
- AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER
- OAT
- TANACETUM PARTHENIUM
- .ALPHA.-TOCOPHEROL ACETATE
- ALLANTOIN
- ETHYLHEXYLGLYCERIN
- PHENOXYETHANOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 70484-001 | 70484-001-01, 70484-001-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 5e48a6a5-93f2-426e-8e7b-b141d57ba375 | aad8dc98-576f-4ceb-9f4c-5487a221a39f | 2016-04-21 | Warnings | 5e48a6a5-93f2-426e-8e7b-b141d57ba375 aad8dc98-576f-4ceb-9f4c-5487a221a39f |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.